{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:06:20Z","timestamp":1789992380909,"version":"4.0.1"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":8210,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1985,3]]},"abstract":"<jats:p><jats:bold>ABSTRACT\u2013 <\/jats:bold> Trihexyphenidyl, a synthetic anticholinergic, used to control ex I rap y ram id al symptoms arising from neuroleptic drug therapy has been a subject of controversy regarding the need for continuous antiparkinsonian therapy. In a group of 22 psychiatric patients receiving long\u2010term anti\u2010psychotic medication concurrently with trihexyphenidyl the effects of trihexyphenidyl withdrawal were studied double\u2010blind and placebo controlled. Anxiety, psychotic symptoms, extrapyramidal symptoms and salivary flow were monitored. Blood pressure, pulse, sleep duration, weight and body temperature were recorded daily. The result was a recognizable withdrawal syndrome indicated by an increase in anxiety with various physical complaints, as well as evidence of orthostatic hypotension and tachycardia. A temporary deterioration was noted in psychotic symptomatology and extra\u2010pyramidal symptoms. The majority of the parameters regained baseline values, indicating the symptoms were related to the discontinuation of trihexyphenidyl and supporting the existence of a withdrawal syndrome.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1985.tb01287.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:23:14Z","timestamp":1187864594000},"page":"297-303","source":"Crossref","is-referenced-by-count":27,"title":["Withdrawal of trihexyphenidyl"],"prefix":"10.1111","volume":"71","author":[{"given":"M.","family":"Mclnnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Petursson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.135.6.509"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.141.2.211"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.113.495.213"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750220084016"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1971.01750170026005"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.124.2.151"},{"key":"e_1_2_1_8_2","first-page":"538","article-title":"Lack of indication for use of antiparkinsonian medication","volume":"32","author":"Pecknold J C","year":"1971","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(70)71583-1"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198303000-00006"},{"key":"e_1_2_1_11_2","first-page":"934","article-title":"Effect of withdrawal of antiparkinisoni\u00e9n meditation in chronically hospitalized psychiatric patients","volume":"47","author":"Ananth J V","year":"1970","journal-title":"Laval Medical"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.142.2.166"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760130049008"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280093010"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.2.184"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198110000-00010"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1981.tb00646.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.12.1567"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/ajp.1979.136.4a.459","article-title":"Trihexyphenidyl abuse for euphorigenic effect","volume":"156","author":"Goggin D","year":"1979","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.7.809"},{"key":"e_1_2_1_21_2","first-page":"351","article-title":"Abuse of antiparkinson drugs: A review of the literature","volume":"41","author":"Smith J M","year":"1980","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_22_2","first-page":"449","article-title":"Uses and toxicity of Belladonna alkaloids and synthetic anticholinergics","volume":"3","author":"Shader R I","year":"1971","journal-title":"Semin Psychiatry"},{"key":"e_1_2_1_23_2","first-page":"353","article-title":"Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication","volume":"38","author":"Jellinek T.","year":"1977","journal-title":"Dis Nerv Syst"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198308000-00033"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb02528.x"},{"key":"e_1_2_1_26_2","unstructured":"McInnisM PeturssonH.Physiostigmine and trinexyphenidyl toxic psychosis.Nord Psykiatr Tidsskr: in press."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","unstructured":"SimpsonG M AngusJ W.A rating scale for estrapyramidal side effects.Acta Psychiatr Scand1970:Suppl.212:11\u201319.","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_1_30_2","first-page":"29","volume-title":"The psychophysiology of mental illness","author":"Lader M.","year":"1975"},{"key":"e_1_2_1_31_2","first-page":"535","volume-title":"The pharmacological bases of therapeutics","author":"Jaffe J H","year":"1980"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb03733.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5795.276"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1985.tb01287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1985.tb01287.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:14:41Z","timestamp":1697807681000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1985.tb01287.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["10.1111\/j.1600-0447.1985.tb01287.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1985.tb01287.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}